Literature DB >> 1511635

In vivo postantibiotic effect of isepamicin and other aminoglycosides in a thigh infection model in neutropenic mice.

F Minguez Minguez1, J Izquierdo Izquierdo, M M Caminero, F Fuentes Martinez, J Prieto Prieto.   

Abstract

The object of this work is to study in neutropenic mice the in vivo postantibiotic effect (PAE) of isepamicin, a new aminoglycoside, gentamicin and netilmicin on Staphylococcus aureus and Escherichia coli and in vivo killing kinetics using two different schedules (A and B) of isepamicin and gentamicin administration against S. aureus: (A) at time zero and every hour up to the 7th or 9th hour and (B) two doses only, at time zero and at the end of the PAE. The PAE of the three aminoglycosides was long (3-5 h), showing that of isepamicin to be the largest, especially on S. aureus. Both A and B treatment models show the same effectiveness for the two tested drugs. These results support the idea that the major significance of the PAE is in its application to dosing regimens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1511635     DOI: 10.1159/000238960

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  2 in total

1.  Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli.

Authors:  F Fuentes; J Izquierdo; M M Martín; M L Gomez-Lus; J Prieto
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

2.  In vitro activity and post-antibiotic effects of linezolid in combination with fosfomycin against clinical isolates of Staphylococcus aureus.

Authors:  Hao Chen; Lan Li; Yanyan Liu; Maomao Wu; Shuangli Xu; Guijun Zhang; Caifen Qi; Yan Du; Mingli Wang; Jiabin Li; Xiaohui Huang
Journal:  Infect Drug Resist       Date:  2018-11-01       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.